Papers
1
Total Citations
27
H-Index
1
About
Dr. Emily White is a pioneering hematology researcher whose work focuses on developing novel therapeutic strategies for beta-hemoglobinopathies, including sickle cell disease and beta-thalassemia. Her major contribution lies in the discovery and validation of small-molecule inducers of fetal hemoglobin (HbF), a critical approach to ameliorating the clinical severity of these debilitating blood disorders. In her landmark 2015 study, cited 27 times, Dr. White adapted a high-throughput screening (HTS) platform using a LCR-γ-globin promoter-GFP reporter assay to identify novel compounds that reactivate fetal globin gene expression. She demonstrated that these agents are not only effective in vitro but also active in vivo in anemic baboons and transgenic mice, representing a significant translational advance. This work has opened new avenues for developing safe, orally bioavailable therapies that could benefit millions of patients worldwide who currently have limited treatment options. Dr. White’s innovative integration of robotic screening with preclinical validation exemplifies how cutting-edge technology can accelerate drug discovery for rare genetic diseases.
Research Focus
Key Achievements
Top Papers
- 1